QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 233 filers reported holding QIAGEN NV in Q2 2018. The put-call ratio across all filers is 4.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,085 | -96.6% | 6,570 | -96.4% | 0.02% | -89.2% |
| Q2 2020 | $7,874,000 | +2.9% | 183,938 | 0.0% | 0.20% | +0.5% |
| Q1 2020 | $7,652,000 | +23.3% | 183,938 | +0.1% | 0.20% | +132.2% |
| Q4 2019 | $6,208,000 | -47.7% | 183,673 | -48.9% | 0.09% | -37.9% |
| Q3 2019 | $11,861,000 | -16.9% | 359,757 | +2.2% | 0.14% | -49.6% |
| Q2 2019 | $14,279,000 | -12.9% | 352,122 | -12.7% | 0.28% | -15.8% |
| Q1 2019 | $16,402,000 | +3.5% | 403,192 | -12.3% | 0.33% | -3.2% |
| Q4 2018 | $15,841,000 | +1.5% | 459,815 | +11.6% | 0.34% | +4.3% |
| Q3 2018 | $15,606,000 | +208.5% | 411,996 | +194.5% | 0.33% | +153.5% |
| Q2 2018 | $5,059,000 | -47.4% | 139,914 | -53.0% | 0.13% | -52.6% |
| Q1 2018 | $9,627,000 | -12.1% | 297,955 | -15.9% | 0.27% | -14.2% |
| Q4 2017 | $10,956,000 | -35.1% | 354,205 | -33.9% | 0.32% | -41.1% |
| Q3 2017 | $16,885,000 | +11.9% | 536,024 | +19.1% | 0.54% | +21.2% |
| Q2 2017 | $15,088,000 | – | 449,990 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |